0001179110-17-001952.txt : 20170208 0001179110-17-001952.hdr.sgml : 20170208 20170208162427 ACCESSION NUMBER: 0001179110-17-001952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170206 FILED AS OF DATE: 20170208 DATE AS OF CHANGE: 20170208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weber David M CENTRAL INDEX KEY: 0001399519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 17582817 BUSINESS ADDRESS: BUSINESS PHONE: 925-600-8826 MAIL ADDRESS: STREET 1: 2341 ROMANO CIRCLE CITY: PLEASANTON STATE: CA ZIP: 94566 4 1 edgar.xml FORM 4 - X0306 4 2017-02-06 0 0000815094 ABIOMED INC ABMD 0001399519 Weber David M C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS MA 01923 0 1 0 0 Chief Operating Officer Common Stock, $.01 par value 2017-02-06 4 M 0 21250 5.86 A 123771 D Common Stock, $.01 par value 2017-02-06 4 S 0 500 105.3680 D 123271 D Common Stock, $.01 par value 2017-02-06 4 S 0 3200 106.8891 D 120071 D Common Stock, $.01 par value 2017-02-06 4 S 0 6130 107.7193 D 113941 D Common Stock, $.01 par value 2017-02-06 4 S 0 6361 108.6569 D 107580 D Common Stock, $.01 par value 2017-02-06 4 S 0 5059 109.7788 D 102521 D Stock Option (right to buy) 5.86 2017-02-06 4 M 0 14000 0 D 2010-05-28 2019-05-28 Common Stock 14000 0 D Stock Options (right to buy) 5.86 2017-02-06 4 M 0 7250 0 D 2010-03-31 2019-05-28 Common Stock 7250 21250 D Stock Option (right to buy) 10.03 2011-06-03 2020-06-03 Common Stock 0 50000 D Stock Option (right to buy) 22.44 2013-05-22 2022-05-22 Common Stock 0 25000 D Stock Option (Right to Buy) 23.15 2014-05-14 2023-05-14 Common Stock 0 23000 D Stock Option (Right to Buy) 21.55 2015-05-14 2024-05-14 Common Stock 0 15000 D Stock Option (right to buy) 66.25 2016-05-13 2025-05-13 Common Stock 0 10000 D Stock Option (right to buy) 99.62 2017-05-24 2026-05-24 Common Stock 0 7000 D This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $105.1100 and $105.7900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $106.2300 and $107.1700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $107.2500 and $108.2400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $108.2600 and $109.2100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $109.3300 and $110.1600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. /s/ Stephen C. McEvoy (by power of attorney) 2017-02-08 EX-24 2 ex24weber.txt LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Stephen C. McEvoy, Ian W. McLeod, Michael Dube and Linda Day, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 29th day of May, 2009 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ David M Weber Print Name: David M Weber